315 related articles for article (PubMed ID: 27111286)
21. Cardiac lineage protein-1 (CLP-1) regulates cardiac remodeling via transcriptional modulation of diverse hypertrophic and fibrotic responses and angiotensin II-transforming growth factor β (TGF-β1) signaling axis.
Mascareno E; Galatioto J; Rozenberg I; Salciccioli L; Kamran H; Lazar JM; Liu F; Pedrazzini T; Siddiqui MA
J Biol Chem; 2012 Apr; 287(16):13084-93. PubMed ID: 22308025
[TBL] [Abstract][Full Text] [Related]
22. The association between microRNA-21 and hypertension-induced cardiac remodeling.
Watanabe K; Narumi T; Watanabe T; Otaki Y; Takahashi T; Aono T; Goto J; Toshima T; Sugai T; Wanezaki M; Kutsuzawa D; Kato S; Tamura H; Nishiyama S; Takahashi H; Arimoto T; Shishido T; Watanabe M
PLoS One; 2020; 15(2):e0226053. PubMed ID: 32040481
[TBL] [Abstract][Full Text] [Related]
23. Macrophage-stimulated cardiac fibroblast production of IL-6 is essential for TGF β/Smad activation and cardiac fibrosis induced by angiotensin II.
Ma F; Li Y; Jia L; Han Y; Cheng J; Li H; Qi Y; Du J
PLoS One; 2012; 7(5):e35144. PubMed ID: 22574112
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension.
Ichihara S; Senbonmatsu T; Price E; Ichiki T; Gaffney FA; Inagami T
Circulation; 2001 Jul; 104(3):346-51. PubMed ID: 11457756
[TBL] [Abstract][Full Text] [Related]
25. Dapagliflozin: a sodium-glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced cardiac fibrotic remodeling by regulating TGFβ1/Smad signaling.
Zhang Y; Lin X; Chu Y; Chen X; Du H; Zhang H; Xu C; Xie H; Ruan Q; Lin J; Liu J; Zeng J; Ma K; Chai D
Cardiovasc Diabetol; 2021 Jun; 20(1):121. PubMed ID: 34116674
[TBL] [Abstract][Full Text] [Related]
26. Endoplasmic Reticulum Protein TXNDC5 Augments Myocardial Fibrosis by Facilitating Extracellular Matrix Protein Folding and Redox-Sensitive Cardiac Fibroblast Activation.
Shih YC; Chen CL; Zhang Y; Mellor RL; Kanter EM; Fang Y; Wang HC; Hung CT; Nong JY; Chen HJ; Lee TH; Tseng YS; Chen CN; Wu CC; Lin SL; Yamada KA; Nerbonne JM; Yang KC
Circ Res; 2018 Apr; 122(8):1052-1068. PubMed ID: 29535165
[TBL] [Abstract][Full Text] [Related]
27. MircroRNA-145 Attenuates Cardiac Fibrosis Via Regulating Mitogen-Activated Protein Kinase Kinase Kinase 3.
Liu Y; Hu J; Wang W; Wang Q
Cardiovasc Drugs Ther; 2023 Aug; 37(4):655-665. PubMed ID: 35416554
[TBL] [Abstract][Full Text] [Related]
28. ADAMTS16 activates latent TGF-β, accentuating fibrosis and dysfunction of the pressure-overloaded heart.
Yao Y; Hu C; Song Q; Li Y; Da X; Yu Y; Li H; Clark IM; Chen Q; Wang QK
Cardiovasc Res; 2020 Apr; 116(5):956-969. PubMed ID: 31297506
[TBL] [Abstract][Full Text] [Related]
29. Upregulation of Transient Receptor Potential Canonical Type 3 Channel via AT1R/TGF-
He R; Zhang J; Luo D; Yu Y; Chen T; Yang Y; Yu F; Li M
Oxid Med Cell Longev; 2019; 2019():4025496. PubMed ID: 31871548
[TBL] [Abstract][Full Text] [Related]
30. Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient mice.
Zhang ZZ; Shang QH; Jin HY; Song B; Oudit GY; Lu L; Zhou T; Xu YL; Gao PJ; Zhu DL; Penninger JM; Zhong JC
J Transl Med; 2013 Sep; 11():229. PubMed ID: 24067190
[TBL] [Abstract][Full Text] [Related]
31. Soluble transforming growth factor-beta1 receptor II might inhibit transforming growth factor-beta-induced myofibroblast differentiation and improve ischemic cardiac function after myocardial infarction in rats.
Lian R; Chen Y; Xu Z; Zhang X
Coron Artery Dis; 2010 Sep; 21(6):369-77. PubMed ID: 20613497
[TBL] [Abstract][Full Text] [Related]
32. Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart.
Li Y; Kishimoto I; Saito Y; Harada M; Kuwahara K; Izumi T; Takahashi N; Kawakami R; Tanimoto K; Nakagawa Y; Nakanishi M; Adachi Y; Garbers DL; Fukamizu A; Nakao K
Circulation; 2002 Sep; 106(13):1722-8. PubMed ID: 12270869
[TBL] [Abstract][Full Text] [Related]
33. Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7).
Grobe JL; Mecca AP; Lingis M; Shenoy V; Bolton TA; Machado JM; Speth RC; Raizada MK; Katovich MJ
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H736-42. PubMed ID: 17098828
[TBL] [Abstract][Full Text] [Related]
34. Up-regulation of Nrf2/HO-1 and inhibition of TGF-β1/Smad2/3 signaling axis by daphnetin alleviates transverse aortic constriction-induced cardiac remodeling in mice.
Syed AM; Kundu S; Ram C; Kulhari U; Kumar A; Mugale MN; Mohapatra P; Murty US; Sahu BD
Free Radic Biol Med; 2022 Jun; 186():17-30. PubMed ID: 35513128
[TBL] [Abstract][Full Text] [Related]
35. Steroidogenic acute regulatory protein/aldosterone synthase mediates angiotensin II-induced cardiac fibrosis and hypertrophy.
Zhang WW; Zheng RH; Bai F; Sturdivant K; Wang NP; James EA; Bose HS; Zhao ZQ
Mol Biol Rep; 2020 Feb; 47(2):1207-1222. PubMed ID: 31820314
[TBL] [Abstract][Full Text] [Related]
36. Antagonist of C5aR prevents cardiac remodeling in angiotensin II-induced hypertension.
Zhang C; Li Y; Wang C; Wu Y; Du J
Am J Hypertens; 2014 Jun; 27(6):857-64. PubMed ID: 24419904
[TBL] [Abstract][Full Text] [Related]
37. Impaired vascular contractility and aortic wall degeneration in fibulin-4 deficient mice: effect of angiotensin II type 1 (AT1) receptor blockade.
Moltzer E; te Riet L; Swagemakers SM; van Heijningen PM; Vermeij M; van Veghel R; Bouhuizen AM; van Esch JH; Lankhorst S; Ramnath NW; de Waard MC; Duncker DJ; van der Spek PJ; Rouwet EV; Danser AH; Essers J
PLoS One; 2011; 6(8):e23411. PubMed ID: 21858106
[TBL] [Abstract][Full Text] [Related]
38. Transforming growth factor-beta-dependent and -independent pathways of induction of tubulointerstitial fibrosis in beta6(-/-) mice.
Ma LJ; Yang H; Gaspert A; Carlesso G; Barty MM; Davidson JM; Sheppard D; Fogo AB
Am J Pathol; 2003 Oct; 163(4):1261-73. PubMed ID: 14507636
[TBL] [Abstract][Full Text] [Related]
39. Novel mechanism of cardiac protection by valsartan: synergetic roles of TGF-β1 and HIF-1α in Ang II-mediated fibrosis after myocardial infarction.
Sui X; Wei H; Wang D
J Cell Mol Med; 2015 Aug; 19(8):1773-82. PubMed ID: 25823960
[TBL] [Abstract][Full Text] [Related]
40. Angiotensin II upregulates Kv1.5 expression through ROS-dependent transforming growth factor-beta1 and extracellular signal-regulated kinase 1/2 signalings in neonatal rat atrial myocytes.
Lu G; Xu S; Peng L; Huang Z; Wang Y; Gao X
Biochem Biophys Res Commun; 2014 Nov; 454(3):410-6. PubMed ID: 25451261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]